These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32925083)

  • 1. Use of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) in X-Linked Myotubular Myopathy: Content Validity and Psychometric Performance.
    Duong T; Harding G; Mannix S; Abel C; Phillips D; Alfano LN; Bönnemann CG; Lilien C; Lowes LP; Servais L; Warken-Madelung B; Nieto Bergman S; James ES; Noursalehi M; Prasad S; Rico S; Bilder DA
    J Neuromuscul Dis; 2021; 8(1):63-77. PubMed ID: 32925083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial.
    Lawlor MW; Schoser B; Margeta M; Sewry CA; Jones KA; Shieh PB; Kuntz NL; Smith BK; Dowling JJ; Müller-Felber W; Bönnemann CG; Seferian AM; Blaschek A; Neuhaus S; Foley AR; Saade DN; Tsuchiya E; Qasim UR; Beatka M; Prom MJ; Ott E; Danielson S; Krakau P; Kumar SN; Meng H; Vanden Avond M; Wells C; Gordish-Dressman H; Beggs AH; Christensen S; Conner E; James ES; Lee J; Sadhu C; Miller W; Sepulveda B; Varfaj F; Prasad S; Rico S
    EBioMedicine; 2024 Jan; 99():104894. PubMed ID: 38086156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An algorithm for discontinuing mechanical ventilation in boys with x-linked myotubular myopathy after positive response to gene therapy: the ASPIRO experience.
    Graham RJ; Amin R; Demirel N; Edel L; Lilien C; MacBean V; Rafferty GF; Sawnani H; Schön C; Smith BK; Syed F; Sarazen M; Prasad S; Rico S; Perez GF
    Respir Res; 2024 Sep; 25(1):342. PubMed ID: 39285418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial.
    Shieh PB; Kuntz NL; Dowling JJ; Müller-Felber W; Bönnemann CG; Seferian AM; Servais L; Smith BK; Muntoni F; Blaschek A; Foley AR; Saade DN; Neuhaus S; Alfano LN; Beggs AH; Buj-Bello A; Childers MK; Duong T; Graham RJ; Jain M; Coats J; MacBean V; James ES; Lee J; Mavilio F; Miller W; Varfaj F; Murtagh M; Han C; Noursalehi M; Lawlor MW; Prasad S; Rico S
    Lancet Neurol; 2023 Dec; 22(12):1125-1139. PubMed ID: 37977713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability.
    Glanzman AM; Mazzone E; Main M; Pelliccioni M; Wood J; Swoboda KJ; Scott C; Pane M; Messina S; Bertini E; Mercuri E; Finkel RS
    Neuromuscul Disord; 2010 Mar; 20(3):155-61. PubMed ID: 20074952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy.
    Dowling JJ; Müller-Felber W; Smith BK; Bönnemann CG; Kuntz NL; Muntoni F; Servais L; Alfano LN; Beggs AH; Bilder DA; Blaschek A; Duong T; Graham RJ; Jain M; Lawlor MW; Lee J; Coats J; Lilien C; Lowes LP; MacBean V; Neuhaus S; Noursalehi M; Pitts T; Finlay C; Christensen S; Rafferty G; Seferian AM; Tsuchiya E; James ES; Miller W; Sepulveda B; Vila MC; Prasad S; Rico S; Shieh PB;
    J Neuromuscul Dis; 2022; 9(4):503-516. PubMed ID: 35694931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput transcriptome analyses from ASPIRO, a phase 1/2/3 study of gene replacement therapy for X-linked myotubular myopathy.
    Andreoletti G; Romano O; Chou HJ; Sefid-Dashti MJ; Grilli A; Chen C; Lakshman N; Purushothaman P; Varfaj F; Mavilio F; Bicciato S; Urbinati F
    Am J Hum Genet; 2023 Oct; 110(10):1648-1660. PubMed ID: 37673065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing X-linked Myotubular Myopathy - A German 20-year Follow Up Experience.
    Gangfuss A; Schmitt D; Roos A; Braun F; Annoussamy M; Servais L; Schara-Schmidt U
    J Neuromuscul Dis; 2021; 8(1):79-90. PubMed ID: 33164942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and respiratory support in X-linked myotubular myopathy: a RECENSUS retrospective analysis.
    Graham RJ; Muntoni F; Hughes I; Yum SW; Kuntz NL; Yang ML; Byrne BJ; Prasad S; Alvarez R; Genetti CA; Haselkorn T; James ES; LaRusso LB; Noursalehi M; Rico S; Beggs AH
    Arch Dis Child; 2020 Apr; 105(4):332-338. PubMed ID: 31484632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A healthcare claims analysis to identify and characterize patients with suspected X-Linked Myotubular Myopathy (XLMTM) in the Brazilian Healthcare System.
    Souza PVS; Haselkorn T; Baima J; Oliveira RW; Hernández F; Birck MG; França MC
    Orphanet J Rare Dis; 2024 May; 19(1):188. PubMed ID: 38715109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of a Neurological Scoring System for Canine X-Linked Myotubular Myopathy.
    Snyder JM; Meisner A; Mack D; Goddard M; Coulter IT; Grange R; Childers MK
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):131-7. PubMed ID: 26086764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the Quality-of-Life Impact of X-Linked Myotubular Myopathy.
    Lloyd A; Aggio D; Slocomb TL; Lee J; Beggs AH; Bilder DA
    J Neuromuscul Dis; 2021; 8(6):1047-1061. PubMed ID: 34250946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States.
    Graham RJ; Darras BT; Haselkorn T; Fisher D; Genetti CA; Miller W; Beggs AH
    Orphanet J Rare Dis; 2023 Jun; 18(1):138. PubMed ID: 37280644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND).
    Glanzman AM; McDermott MP; Montes J; Martens WB; Flickinger J; Riley S; Quigley J; Dunaway S; O'Hagen J; Deng L; Chung WK; Tawil R; Darras BT; Yang M; Sproule D; De Vivo DC; Kaufmann P; Finkel RS; ;
    Pediatr Phys Ther; 2011; 23(4):322-6. PubMed ID: 22090068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic Cholestasis Is a Clinically Significant Feature Associated with Natural History of X-Linked Myotubular Myopathy (XLMTM): A Case Series and Biopsy Report.
    Molera C; Sarishvili T; Nascimento A; Rtskhiladze I; Muñoz Bartolo G; Fernández Cebrián S; Valverde Fernández J; Muñoz Cabello B; Graham RJ; Miller W; Sepulveda B; Kamath BM; Meng H; Lawlor MW
    J Neuromuscul Dis; 2022; 9(1):73-82. PubMed ID: 34366366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.
    Biancalana V; Scheidecker S; Miguet M; Laquerrière A; Romero NB; Stojkovic T; Abath Neto O; Mercier S; Voermans N; Tanner L; Rogers C; Ollagnon-Roman E; Roper H; Boutte C; Ben-Shachar S; Lornage X; Vasli N; Schaefer E; Laforet P; Pouget J; Moerman A; Pasquier L; Marcorelle P; Magot A; Küsters B; Streichenberger N; Tranchant C; Dondaine N; Schneider R; Gasnier C; Calmels N; Kremer V; Nguyen K; Perrier J; Kamsteeg EJ; Carlier P; Carlier RY; Thompson J; Boland A; Deleuze JF; Fardeau M; Zanoteli E; Eymard B; Laporte J
    Acta Neuropathol; 2017 Dec; 134(6):889-904. PubMed ID: 28685322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Genotype-Phenotype Correlations in X-Linked Myotubular Myopathy and the Use of the Face2Gene Application as an Effective Non-Invasive Diagnostic Tool.
    Kušíková K; Šoltýsová A; Ficek A; Feichtinger RG; Mayr JA; Škopková M; Gašperíková D; Kolníková M; Ornig K; Kalev O; Weis S; Weis D
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38136996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial hemorrhage secondary to vitamin K deficiency in X-linked myotubular myopathy.
    Neese JM; Yum S; Matesanz S; Raffini LJ; Whitworth HB; Loomes KM; Mayer OH; Alcamo AM
    Neuromuscul Disord; 2021 Jul; 31(7):651-655. PubMed ID: 34120822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.
    Mack DL; Poulard K; Goddard MA; Latournerie V; Snyder JM; Grange RW; Elverman MR; Denard J; Veron P; Buscara L; Le Bec C; Hogrel JY; Brezovec AG; Meng H; Yang L; Liu F; O'Callaghan M; Gopal N; Kelly VE; Smith BK; Strande JL; Mavilio F; Beggs AH; Mingozzi F; Lawlor MW; Buj-Bello A; Childers MK
    Mol Ther; 2017 Apr; 25(4):839-854. PubMed ID: 28237839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gait characteristics in a canine model of X-linked myotubular myopathy.
    Goddard MA; Burlingame E; Beggs AH; Buj-Bello A; Childers MK; Marsh AP; Kelly VE
    J Neurol Sci; 2014 Nov; 346(1-2):221-6. PubMed ID: 25281397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.